Get PACE removed from clinical guidelines – sign the petition!
Sasha invites you to sign a new petition to the HHS to protect patients against the PACE trial, CBT and GET ...
Discuss the article on the Forums.

Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.

Discussion in 'Other Health News and Research' started by Ecoclimber, Jun 12, 2013.

  1. Ecoclimber

    Ecoclimber Senior Member

    Int J Mol Sci. 2013 May 31;14(6):11742-66. doi: 10.3390/ijms140611742.
    Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.
    Lin GJ, Huang SH, Chen SJ, Wang CH, Chang DM, Sytwu HK.
    Department of Biology and Anatomy, National Defense Medical Center, No. 161, Section 6, MinChuan East Road, Neihu, Taipei City 114, Taiwan.


    Melatonin is the major secretory product of the pineal gland during the night and has multiple activities including the regulation of circadian and seasonal rhythms, and antioxidant and anti-inflammatory effects. It also possesses the ability to modulate immune responses by regulation of the T helper 1/2 balance and cytokine production. Autoimmune diseases, which result from the activation of immune cells by autoantigens released from normal tissues, affect around 5% of the population. Activation of autoantigen-specific immune cells leads to subsequent damage of target tissues by these activated cells. Melatonin therapy has been investigated in several animal models of autoimmune disease, where it has a beneficial effect in a number of models excepting rheumatoid arthritis, and has been evaluated in clinical autoimmune diseases including rheumatoid arthritis and ulcerative colitis. This review summarizes and highlights the role and the modulatory effects of melatonin in several inflammatory autoimmune diseases including


    Attached Files:

See more popular forum discussions.

Share This Page